Results 271 to 280 of about 129,283 (392)
Double-blind controlled trial of azathioprine in the treatment of multiple sclerosis. [PDF]
openalex +1 more source
Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka+4 more
wiley +1 more source
A Severe Case of Nuclear Matrix Protein-2-Positive Dermatomyositis With Negative Malignancy Workup. [PDF]
Kondle S, Cohen S.
europepmc +1 more source
A case of post-infectious anti-myelin oligodendrocyte glycoprotein antibody-positive optic neuritis. [PDF]
Son YB, Kim KH, Choi HY, Jeon H.
europepmc +1 more source
Infliximab in Autoimmune Inner Ear Disease: A Case Report. [PDF]
Millan P, Sunmboye KO.
europepmc +1 more source
Azathioprine for people with multiple sclerosis. [PDF]
Ridley B+5 more
europepmc +1 more source
Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis
Summary Linear immunoglobulin A (IgA) bullous dermatosis (LABD), also referred to as chronic bullous disease of childhood (CBDC), is characterized by the linear deposition of IgA antibodies within the dermal‐epidermal junction. While dapsone is typically recommended, alternative modalities may be considered based on accessibility, severity, and prior ...
Kristie Mar+7 more
wiley +1 more source
A Presentation of Strawberry Gingivitis as the Initial Presenting Symptom of Recurrence of Granulomatosis With Polyangiitis. [PDF]
McPhail MN+5 more
europepmc +1 more source